Vivodyne to Replace Animal Testing With $40 Million Funding to Reverse 95% Clinical Trial Failure Rate
SAN FRANCISCO & PHILADELPHIA–(BUSINESS WIRE)–Biopharmaceutical companies routinely cure diseases in animals during preclinical testing, yet those same therapies fail in human clinical trials nearly 95% of the time. By shifting from animals to an exclusively human optimization…